L04AF01
Spain-
Xeljanz 1 mg/ml oral solution
Form: solution, oral
Active substance Dosage TOFACITINIB CITRATE 1,62 mg ATC code: L04A, L04AF, L04AF01
Manufacturer: Pfizer Europe Ma Eeig
-
Xeljanz 10 mg film-coated tablets
Form: tablets, film-coated
Active substance Dosage TOFACITINIB CITRATE 16,155 mg ATC code: L04A, L04AF, L04AF01
Manufacturer: Pfizer Europe Ma Eeig
-
Xeljanz 11 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage TOFACITINIB CITRATE 17,77 mg ATC code: L04A, L04AF, L04AF01
Manufacturer: Pfizer Europe Ma Eeig
-
Xeljanz 5 mg film-coated tablets
Form: tablets, film-coated
Active substance Dosage TOFACITINIB CITRATE 8,078 mg ATC code: L04A, L04AF, L04AF01
Manufacturer: Pfizer Europe Ma Eeig